Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Jakubowski
    Jakubowski
  4. Shah
    Shah
  5. Papadopoulos
    Papadopoulos
  6. Scordo
    Scordo
  7. Devlin
    Devlin
  8. Landau
    Landau
  9. Ponce
    Ponce
  10. Castro-Malaspina
    Castro-Malaspina

Groups

  1. Hematologic Malignancies, Division of (1609)
  2. Department of Medicine (1594)
  3. Center for Hematologic Malignancies (1283)
  4. Bone Marrow Transplant (734)
  5. Survivorship Research (509)
  6. GSK Faculty (414)
  7. CTCR Scholars (318)
  8. Sloan Kettering Institute Faculty (307)
  9. Epidemiology and Biostatistics (303)
  10. Biostatistics Service (291)
Search Within
  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (829)
  2. Journal Article (637)
  3. Review (67)
  4. Guidelines (24)
  5. Editorial (19)
  6. Book Section (14)
  7. Conference Paper (11)
  8. Correspondence (4)
  9. Research Letter (3)
  10. Miscellaneous (1)
Groups
  1. Hematologic Malignancies, Division of (1609)
  2. Department of Medicine (1594)
  3. Center for Hematologic Malignancies (1283)
  4. Bone Marrow Transplant (734)
  5. Survivorship Research (509)
  6. GSK Faculty (414)

More Groups

People
  1. Sergio Giralt (384)
  2. Miguel-Angel Perales (300)
  3. Sean Devlin (172)
  4. Ann Jakubowski (164)
  5. Juliet Barker (157)
  6. Marcel Van Den Brink (150)

More People

Years
  1. 2025 (25)
  2. 2024 (96)
  3. 2023 (129)
  4. 2022 (144)
  5. 2021 (104)
  6. 2020 (159)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (596)
  2. Clinical Lymphoma, Myeloma and Leukemia (328)
  3. Transplantation and Cellular Therapy (127)
  4. Gynecologic Oncology (95)
  5. International Journal of Radiation Oncology, Biology, Physics (66)
  6. Journal of Thoracic Oncology (55)

More Publications

Results (1609)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II randomized trial comparing proton craniospinal irradiation with photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis
    Meeting Abstract

    Yang, J. T.; Wijetunga, N. A.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Betof Warner, A.; Yu, H.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Tumor mutational burden predicts progression-free survival and local-regional control in locally advanced non-small cell lung cancer patients treated with chemoradiation and durvalumab
    Meeting Abstract

    Shaverdian, N.; Shepherd, A. F.; Offin, M.; Gelblum, D.; Wu, A. J.; Simone, C. B. 2nd; Schoenfeld, A. J.; Jones, D.; Rimner, A.; Chaft, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • FOLFOX-based chemoradiation as non-operative management for esophageal adenocarcinoma
    Meeting Abstract

    Rouf, R.; Ku, G.; Cowzer, D.; Harrington, C.; Maron, S.; Janjigian, Y.; Ilson, D. H.; Molena, D.; Sihag, S.; Hajj, C.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Characteristics of patients who survived more than 5 years after diagnosis of melanoma brain metastases
    Meeting Abstract

    Gui, C.; Wolchok, J. D.; Postow, M. A.; Betof Warner, A.; Loo, K.; Brennan, C. W.; Moss, N. S.; Tabar, V. S.; Beal, K.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Role of CD19 chimeric antigen receptor T cells in second-line large B cell lymphoma: Lessons from phase 3 trials. An expert panel opinion from the American Society for Transplantation and Cellular Therapy
    Review

    Perales, M. A.; Anderson, L. D. Jr; Jain, T.; Kenderian, S. S.; Oluwole, O. O.; Shah, G. L.; Svoboda, J.; Hamadani, M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Real-world evidence of axicabtagene ciloleucel for the treatment of Large B cell lymphoma in the United States
    Journal Article

    Jacobson, C. A.; Locke, F. L.; Ma, L.; Asubonteng, J.; Hu, Z. H.; Siddiqi, T.; Ahmed, S.; Ghobadi, A.; Miklos, D. B.; Lin, Y.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • ASTCT Committee on Practice Guidelines survey on Evaluation & management of diffuse large B-cell lymphoma after failure of chimeric antigen receptor T cell therapy (CAR-T) therapy
    Journal Article

    Ahmed, N.; Kumar, A.; Kharfan-Dabaja, M. A.; DeFilipp, Z.; Herrera, A.; Hashmi, S.; Dholaria, B.; Perales, M. A.; Carpenter, P. A.; Hamadani, M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Land(mark) ahoy: PFS24 in relapsed/refractory diffuse large B-cell lymphoma
    Editorial

    Matasar, M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
    Guidelines

    Stacchiotti, S.; Maria Frezza, A.; Demetri, G. D.; Blay, J. Y.; Bajpai, J.; Baldi, G. G.; Baldini, E. H.; Benjamin, R. S.; Bonvalot, S.; Bovée, J. V. M. G.; more...
    Cancer Treatment Reviews (2022)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T cells and management of toxicities: Implications of biomarkers
    Book Section

    Wudhikarn, K.; Alarcón Tomas, A.; Murata, K.; Perales, M. A.
    In Ramanathan, L. V.; Fleisher, M.; Duffy, M. J. (Eds.) Cancer Biomarkers: Clinical Aspects and Laboratory Determination (2022)

    Fulltext@MSK | Save